New Translational Research Models for Battling Rare Diseases
Beth Anne Baber,
Co-Founder, CEO, and President
The Nicholas Conor Institute for Pediatric Cancer Research

Abstract: The Nicholas Conor Institute is a non-profit medical research organization that supports the transition of pediatric cancer diagnostics and therapies from the research laboratory to the clinic. The Institute employs an innovative model of mutually beneficial partnerships within the biomedical community to promote the development of personalized treatment plans for children with cancer. As an academic institute without walls, the Nicholas Conor has the ability to catalyze further development of promising discoveries and technologies from academia and early-stage industry by creatively addressing the needs of its partners in the biomedical industry. Otherwise, these potentially life saving discoveries would languish due to the small market that children with cancer occupy.

Presenter Biography: Beth Anne has more than 20 years of academic experience in cancer biology and signal transduction. Her current research focuses on the understanding of the molecular mechanisms involved in DNA damage repair following treatment with radiation and chemotherapeutic agents. Her work in DNA damage signaling has led to publications in major scientific journals, including Nature and Science. The National Institute of Health, the Leukemia and Lymphoma Society and the Beckman Laser Institute funded her research initiatives at the Salk Institute. Beth Anne received her PhD in Macromolecular Cellular Structure and Chemistry from The Scripps Research Institute. She is the 2007 DLA Piper-Athena FlexMBA Scholarship recipient and received her MBA from the University of California-San Diego Rady School of Management in August 2009. Beth Anne is the mother of Nicholas Conor Boddy, a pediatric cancer survivor.

Advertisement

ADVERTISEMENT — Advertise With Biotech Networks

Be the first to comment

Leave a Reply

Your email address will not be published.


*